BIOCON.BOBIOCON.BOBSE
Loading
Net Income PerformanceStrong
Percentile Rank93
3Y CAGR+16.0%
5Y CAGR+6.3%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+16.0%/yr
vs +14.9%/yr prior
5Y CAGR
+6.3%/yr
Recent acceleration
Acceleration
+1.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$10.13B-0.9%
2024$10.22B+121.0%
2023$4.63B-28.6%
2022$6.48B-12.4%
2021$7.41B-1.0%
2020$7.48B-17.4%
2019$9.05B+143.1%
2018$3.72B-39.2%
2017$6.12B-31.7%
2016$8.96B-